Daniel T Layish MD FACP, FCCP, FAASM
Critical Care Medicine, Cystic Fibrosis, Pulmonary Vascular Medicine, Sleep Medicine
Vice President, Central Florida Pulmonary Group; Associate Professor of Medicine, University of Central Florida College of Medicine
Join to View Full Profile
1115 E Ridgewood StOrlando, FL 32803
Phone+1 407-841-1100
Fax+1 407-841-0774
Dr. Layish is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a Pulmonary/Critical Care/Sleep Specialist with Central Florida Pulmonary Group, a large single specialty private practice. My hospital work is mostly at Winter Park Hospital. I am co-director of the Adult Cystic Fibrosis Program in Orlando. My clinical interests include Cystic Fibrosis, Pulmonary Hypertension,Alpha-One Antitrypsin Deficiency, Obstructive Sleep Apnea, and LAM
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1997
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1993- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1990 - 1991
Boston University School of MedicineClass of 1990
Certifications & Licensure
FL State Medical License 1997 - 2027
NC State Medical License 1994 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Awards, Honors, & Recognition
- President Southeast Thoracic Advisory Board (American Lung Association)
- President-Elect Southeast Thoracic Association, 2016-2018
- Chairman, Pulmonary Department Florida Hospital System (7 campuses), 2016-2018
- Join now to see all
Clinical Trials
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Start of enrollment: 2008 May 01
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Start of enrollment: 2008 Jul 01
- Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsOral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trialGraham Devereux, Danielle Wrolstad, Stephen J. Bourke, Cori L. Daines, S. Doe
Plos One. 2020-12-28 - 13 citationsLung Transplantation for Williams-Campbell SyndromeScott M. Palmer, Daniel T. Layish, Peter S. Kussin, Tim D. Oury, Robert D. Davis
Chest. 1998-02-01 - 4 citationsNew imaging techniques for the diagnosis of pulmonary embolism.Daniel T. Layish, Victor F. Tapson
Current Opinion in Pulmonary Medicine. 1997-07-01
Press Mentions
Phage Therapy: Legacy of CF Advocate Mallory Smith EnduresMay 27th, 2021
May I Have My Medical Records, Please?March 19th, 2020
Salt Therapy Is Gaining BelieversSeptember 22nd, 2015
Professional Memberships
- Fellow
- Member
- Fellow
- Fellow
- Member
- Member
- Member
Industry Relationships
- Speaker's Panel, GileadSpeaking on behalf of Gilead regarding Cystic Fibrosis and Pulmonary Hypertension2010 - Present
External Links
- Group Websitehttp://www.cfpulmonary.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
